Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 51.88% vs 130.55% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 37.69% vs 65.67% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "217.80",
          "val2": "143.40",
          "chgp": "51.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-38.30",
          "val2": "-25.60",
          "chgp": "-49.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.40",
          "val2": "6.40",
          "chgp": "-46.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.80",
          "val2": "0.30",
          "chgp": "166.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-20.00",
          "val2": "-32.10",
          "chgp": "37.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-175.90%",
          "val2": "-294.50%",
          "chgp": "11.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 37.93% vs 27.88% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 49.07% vs 39.22% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "532.70",
          "val2": "386.20",
          "chgp": "37.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-162.70",
          "val2": "-348.40",
          "chgp": "53.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "29.10",
          "val2": "24.50",
          "chgp": "18.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.90",
          "val2": "8.70",
          "chgp": "-55.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-150.30",
          "val2": "-295.10",
          "chgp": "49.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-420.50%",
          "val2": "-1,058.40%",
          "chgp": "63.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

217.80

143.40

51.88%

Operating Profit (PBDIT) excl Other Income

-38.30

-25.60

-49.61%

Interest

3.40

6.40

-46.88%

Exceptional Items

0.80

0.30

166.67%

Consolidate Net Profit

-20.00

-32.10

37.69%

Operating Profit Margin (Excl OI)

-175.90%

-294.50%

11.86%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 51.88% vs 130.55% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 37.69% vs 65.67% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

532.70

386.20

37.93%

Operating Profit (PBDIT) excl Other Income

-162.70

-348.40

53.30%

Interest

29.10

24.50

18.78%

Exceptional Items

3.90

8.70

-55.17%

Consolidate Net Profit

-150.30

-295.10

49.07%

Operating Profit Margin (Excl OI)

-420.50%

-1,058.40%

63.79%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 37.93% vs 27.88% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 49.07% vs 39.22% in Dec 2023

All Annual Results